ANTONIO GIORDANO
Temple University
H-index: 112
North America-United States
Top articles of ANTONIO GIORDANO
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract PO3-01-09: Results of a prospective observational study evaluating the impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early … | Cancer Research | Chiara Corti Xiangying Chu Pedro Exman Danielle Kline Nolan Priedigkeit | 2024/5/2 |
Dalle cellule ai sistemi. Citologia–Istologia–Anatomia microscopica | G Anastasi I Barajon C Castaldo S Cinti S Corso | 2024 | |
Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A Review | Diletta Rosati Maria Palmieri Giulia Brunelli Andrea Morrione Francesco Iannelli | 2024/3/1 | |
Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma | Heliyon | Angelo Canciello Reyes Benot Domínguez Barbara Barboni Antonio Giordano Andrea Morrione | 2024/3/30 |
Abstract PO2-03-06: Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC) | Cancer Research | Filipa Lynce Samuel Niman Anthony Gonçalves Megumi Kai Sean Ryan | 2024/5/2 |
Is there a role for continuation of CDK4/6 inhibition after progression on a prior CDK4/6 inhibitor in HR+/HER2− metastatic breast cancer? | Annals of Oncology | A Giordano NU Lin SM Tolaney EL Mayer | 2024/1/1 |
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer | Frontiers in Oncology | Toros A Dincman Joseph AQ Karam Antonio Giordano Hong Li Leylah M Drusbosky | 2024/2/21 |
PARP Inhibitors for Breast Cancer Treatment: A Review | Stefania Morganti Antonio Marra Carmine De Angelis Angela Toss Luca Licata | 2024/3/21 | |
Abstract PO2-15-10: Identifying new immune-related biomarkers in TNBC with a look at PD-L1 cell-autonomous role | Cancer Research | Caterina Costa Claudia von Arx Alessandra Calabrese Francesca Pentimalli Mutti Luciano | 2024/5/2 |
Activation of a non-neuronal cholinergic system in visceral white adipose tissue of obese mice and humans | Molecular Metabolism | Ilenia Severi Jessica Perugini Chiara Ruocco Lara Coppi Silvia Pedretti | 2024/1/1 |
CSF-1R in Cancer: More than a Myeloid Cell Receptor | Francesca Cersosimo Silvia Lonardi Cristina Ulivieri Paolo Martini Andrea Morrione | 2024/1/9 | |
Red Orange and Lemon Extract Ameliorates the Renal Oxidative Stress and Inflammation Induced by Ochratoxin A through the Modulation of Nrf2 | Toxins | Consiglia Longobardi Sara Damiano Simona Fabroni Serena Montagnaro Valeria Russo | 2024/3/14 |
Abstract PO3-20-06: TRUDI: A phase II study of neoadjuvant TRastuzumab derUxtecan and Durvalumab for stage III HER2-expressing Inflammatory breast cancer | Cancer Research | Paolo Tarantino Samuel Niman Antonio Giordano Faina Nakhlis Jennifer Bellon | 2024/5/2 |
Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA | Instrumentation Science & Technology | Marcella Barbarino Cristiana Bellan Matilde Pesetti Maria Bottaro Caterina Tomassetti | 2024/1/5 |
CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice | Oncogene | Luigi Alfano Carmelina Antonella Iannuzzi Daniela Barone Iris Maria Forte Maria Carmen Ragosta | 2024/3/4 |
Abstract PO2-20-02: A Phase 3 study of gedatolisib plus fulvestrant with and without palbociclib in patients with HR+/HER2-advanced breast cancer previously treated with a CDK4 … | Cancer Research | Sara Hurvitz Fabrice André Massimo Cristofanilli Giuseppe Curigliano Antonio Giordano | 2024/5/2 |
Abstract PO4-06-07: Efficacy and safety of futibatinib in patients with locally advanced/metastatic triple-negative breast cancer harboring FGFR2 gene amplification: final … | Cancer Research | Antonio Giordano Nisha Unni Senthil Damodaran Hope Rugo Timothy Crook | 2024/5/2 |
THE EFFECTS OF VIRTUAL REALITY ON PAIN AND ANXIETY IN PEDIATRIC ONCOLOGY PATIENTS | of Research | Antonio Giordano | 2024 |
An Exploratory Bioinformatic Investigation of Cats’ Susceptibility to Coronavirus-Deriving Epitopes | Life | Michela Buonocore Davide De Biase Domenico Sorrentino Antonio Giordano Orlando Paciello | 2024/3/2 |
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 | EClinicalMedicine | Jon Salmanton-García Francesco Marchesi Francesca Farina Barbora Weinbergerová Federico Itri | 2024/5/1 |
Co-Authors
